MPC_ Deep Sequencing Reveals Distinct Pattern of DNA Methylation in Prostate Cancer
Source: NCBI BioProject (ID PRJNA188782)
Source: NCBI BioProject (ID PRJNA188782)
0 0
Project name: Homo sapiens
Description: Aberrant DNA methylation changes are known to occur during prostate cancer progression beginning with precursor lesions. Utilizing fifty nanograms of genomic DNA in Methylplex-Next Generation Sequencing (M-NGS) we mapped the global DNA methylation patterns in prostate tissues (n=17) and cells (n=2). Peaks were located from mapped reads obtained in each sequencing run using a Hidden Markov Model (HMM)-based algorithm previously used for Chip-Seq data analysis(http://www.sph.umich.edu/csg/qin/HPeak). The total methylation events in intergenic/intronic regions between benign adjacent and cancer tissues were comparable. Promoter CGI methylation gradually increased from -12.6% in benign samples to 19.3% and 21.8% in localized and metastatic cancer tissues and approximately 20% of all CpG islands (CGIs) (68,508) were methylated in tissues. We observed distinct patterns in promoter methylation around transcription start sites, where methylation occurred directly... (for more see dbGaP study page.)
Data type: Phenotype or Genotype
Sample scope: Multiisolate
Relevance: Medical
Organization: UNIVERSITY OF MICHIGAN